Abstract

Autologous bone marrow transplantation is being used with increasing frequency to treat patients with relapsed or refractory Hodgkin's disease. Patients most likely to benefit from this procedure include those with chemotherapy sensitive disease, good performance status, and limited exposure to conventional chemotherapy regimens. Many questions regarding the optimal timing of transplantation, the most active preparative regimen, and the best source of hematopoietic rescue remain unanswered. Future studies should better define the role of transplantation in Hodgkin's disease and lead to improved results.

Original languageEnglish (US)
Pages (from-to)591-611
Number of pages21
JournalHematology/Oncology Clinics of North America
Volume7
Issue number3
StatePublished - Jan 1 1993

Fingerprint

Autologous Transplantation
Hodgkin Disease
Transplantation
Drug Therapy
Bone Marrow Transplantation

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Role of autotransplantation in Hodgkin's disease. / Bierman, Philip Jay; Armitage, James Olen.

In: Hematology/Oncology Clinics of North America, Vol. 7, No. 3, 01.01.1993, p. 591-611.

Research output: Contribution to journalArticle

@article{97531790ab61499bb0b3b3c8fac233c0,
title = "Role of autotransplantation in Hodgkin's disease",
abstract = "Autologous bone marrow transplantation is being used with increasing frequency to treat patients with relapsed or refractory Hodgkin's disease. Patients most likely to benefit from this procedure include those with chemotherapy sensitive disease, good performance status, and limited exposure to conventional chemotherapy regimens. Many questions regarding the optimal timing of transplantation, the most active preparative regimen, and the best source of hematopoietic rescue remain unanswered. Future studies should better define the role of transplantation in Hodgkin's disease and lead to improved results.",
author = "Bierman, {Philip Jay} and Armitage, {James Olen}",
year = "1993",
month = "1",
day = "1",
language = "English (US)",
volume = "7",
pages = "591--611",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Role of autotransplantation in Hodgkin's disease

AU - Bierman, Philip Jay

AU - Armitage, James Olen

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Autologous bone marrow transplantation is being used with increasing frequency to treat patients with relapsed or refractory Hodgkin's disease. Patients most likely to benefit from this procedure include those with chemotherapy sensitive disease, good performance status, and limited exposure to conventional chemotherapy regimens. Many questions regarding the optimal timing of transplantation, the most active preparative regimen, and the best source of hematopoietic rescue remain unanswered. Future studies should better define the role of transplantation in Hodgkin's disease and lead to improved results.

AB - Autologous bone marrow transplantation is being used with increasing frequency to treat patients with relapsed or refractory Hodgkin's disease. Patients most likely to benefit from this procedure include those with chemotherapy sensitive disease, good performance status, and limited exposure to conventional chemotherapy regimens. Many questions regarding the optimal timing of transplantation, the most active preparative regimen, and the best source of hematopoietic rescue remain unanswered. Future studies should better define the role of transplantation in Hodgkin's disease and lead to improved results.

UR - http://www.scopus.com/inward/record.url?scp=0027222897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027222897&partnerID=8YFLogxK

M3 - Article

C2 - 8344883

AN - SCOPUS:0027222897

VL - 7

SP - 591

EP - 611

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 3

ER -